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Abstract 
In 2004, the National Patient Safety Agency (NSPA) released a safety alert relating to the 
management and use of infusion devices in England and Wales. The alert called for the 
standardisation of infusion devices and a consideration of using centralised equipment systems to 
manage device storage. There has also been growing interest in smart pump technology, such as 
dose error reduction software (DERS) as a way to reduce IV medication errors. However, questions 
remain about the progress that has been made towards infusion device standardisation and the 
adoption of DERS.  
 
We report on the results of a survey investigating the extent to which the standardisation of infusion 
devices has occurred in the last 10 years; how far centralised equipment libraries are being used in 
practice; and about the prevalence of DERS use within the UK.  
 
The findings indicate that while reported standardisation levels are high, the use of centralised 
equipment libraries remains low, as does DERS usage.  
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Key phrases 
1. Infusion device standardisation, the use of centralised equipment libraries and DERS have all 
been suggested as ways to improve patient safety but there has been little research on 
establishing the prevalence of all three on a national level.   
2. WƌŽŐƌĞƐƐ ŚĂƐ ďĞĞŶ ŵĂĚĞ ƚŽǁĂƌĚƐ ŝŶĨƵƐŝŽŶ ĚĞǀŝĐĞ ƐƚĂŶĚĂƌĚŝƐĂƚŝŽŶ ? ŚŽǁĞǀĞƌ  “ƐƚĂŶĚĂƌĚŝƐĂƚŝŽŶ ?
does not always mean that only one type of device is being used, and there is still some 
variability in the devices used across whole organisations. 
3. Due to specific clinical areas requiring different devices or alternative configurations of the same 
device centralised equipment libraries are not the most common method of device storage 
management across entire hospitals. 
4. Due to the significant practical and organisational challenges that face institutions wishing to 
implement DERS, only a small number of hospitals are using this technology, especially across 
entire trusts and health boards.  
5. Obstacles to the implementation of DERS include existing device contracts, the significant time 
and resources required, not being convinced of the technology, and complications related to a 
lack of standardisation.  
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Introduction  
Ten years ago, the National Patient Safety Agency released a safety alert relating to the 
management and use of infusion devices in England and Wales (NPSA, 2004). The alert noted that 
19% of 700 annual incidents involving intravenous infusions were attributed to user error. In order 
to reduce the chances of error occurring, it was argued that NHS organisations should review the 
way in which they purchase, manage and use infusion devices. On the basis of a pilot study in six 
acute trusts, it was also recommended that organisations providing acute care reduce the range of 
device types available (where each type has agreed default configurations) and that centralised 
equipment libraries should be considered a more effective way of managing devices that can also 
improve patient safety. A toolkit was provided by the NPSA, as well as an audit tool to help 
organisations make the changes suggested in order to improve patient safety (Quinn, Stevenson & 
Glenister, 2004).  
 
As a result, organisations have made changes to purchasing policy (NPSA, 2006) and standardisation 
has been shown to be effective (Lee, 2010), where a strategic approach to the ongoing management 
of infusion devices with board level responsibility is recommended to help maintain the high profile 
that these high risk devices and therapy demand (MHRA, 2013). However, since 2004, it is unclear 
the extent to which the standardisation of infusion devices has occurred and how far centralised 
equipment libraries are being used in practice. 
 
In addition, despite design improvements, user error is still blamed for a large proportion of 
incidents involving medical infusion devices, up to 21% according to the Medicines and Healthcare 
Products Regulatory Agency (MHRA, 2013). Nurses are primary users of infusion devices (Iacovides 
et al., 2013), and  “ƐŵĂƌƚƉƵŵƉ ?ƚĞĐŚŶŽůŽŐǇ such as Drug Error Reduction Software (DERS) has been 
presented as beneficial to both nurses and patients (Upton and Quinn, 2013). While the definition of 
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 “sŵĂƌƚ ƉƵŵƉ ? ƚĞĐŚŶŽůŽŐǇ can vary, for the purposes of this review, the term is used to describe 
infusion devices which require additional information about the patient (e.g. weight) and medication 
(e.g. drug name, dose, concentration) to be entered and also performs checks to detect possible 
prescribing and programming errors. /Ŷ ƚŚŝƐ ǁĂǇ ? ƚŚĞ ƐŽĨƚǁĂƌĞ ƉĞƌĨŽƌŵƐ ĂŶ  “ĞůĞĐƚƌŽŶŝĐ ĚŽƵďůĞ
ĐŚĞĐŬ ?ĨŽƌŶƵƌƐĞƐ ?ŽƵƐŝŶƐĞƚĂů ? ? ? ? ? ? ? Limits for maximum and minimum dosages and infusion rates 
can be programmed into the associated software which can also be used to form the basis of a risk 
management plan. Hard limits are fixed and cannot be overridden by the user, whereas soft limits 
can be temporarily overridden depending on therapy and individual circumstances.  
 
It has been suggested that DERS can help to improve patient safety, particularly in intensive care 
(Murdoch and Cameron, 2008), and there are examples of successful implementation within 
particular hospitals (Cousins et al, 2013). Furthermore, Keohane et al (2005) highlight the role of the 
nurse as critical within the selection, implementation and continuing evaluation of smart pump 
technology. However, it has also been argued that the evidence base for DERS use in practice is 
currently limited, particularly within the UK (Hertzel and Souza 2009; Taxis and Franklin, 2011, Lee 
2013). Upton and Quinn (2013) also note that the uptake of DERS within Europe and the UK appears 
much lower when compared to the USA. The reasons they suggest for this include:  
 
x A lack of standardisation of equipment. 
x Low investment in new technology. 
x Resistance to change. 
x Lack of robust evidence of effectiveness. 
x Lack of promotion by manufacturers.  
x The need for greater hospital pharmacy involvement.  
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While 68% of hospitals in the USA were found to be using DERS in 2011 (Pedersen et al, 2012), there 
has not been a similar survey to explore the prevalence of use within UK hospitals is (Cousins et al, 
2013). Understanding current usage would help inform future studies of IV infusion safety and DERS 
usage. 
 
We aimed to address this gap by investigating the following questions in relation to UK hospitals:  
 
1. To what extent are volumetric infusion devices and syringe pumps currently standardised? 
2. How are infusion devices currently stored and management? 
3. How is DERS being used and to what extent? 
 
Method 
An online survey was sent to infusion device managers and trainers within NHS organisations across 
the UK between April  ? July 2013. Respondents were recruited from a previous interview study 
(Iacovides et al., 2013), various mailing lists and websites (e.g. the Institute of Physics and 
Engineering in Medicine mailing list and the National Association of Medical Device Educators and 
Trainers website) and through attempting to directly contact departments within a list of 162 acute 
trusts in England (NHS, 2013). A researcher ĨŝƌƐƚĐŽŶƚĂĐƚĞĚĞĂĐŚƚƌƵƐƚ ?ƐƐǁŝƚĐŚďŽĂƌĚŝŶŽƌĚĞƌƚŽďĞ
put through to the relevant department e.g. Medical Physics, before asking for the contact details of 
someone responsible for infusion device management. As a result of this process, the survey link 
was sent to individuals within 83 trusts (in the other cases, the appropriate individual could not be 
reached). To encourage participation, respondents were given the option to be included in a prize 
draw where they could win one of three £50 vouchers. 
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The survey was hosted online and included questions on standardisation, the pumps in use, how 
they were stored and accessed, and details of any DERS use.   
 
Results  
In total, forty five respondents participated in the study. These included NHS staff who were 
involved in medical device management, maintenance and/or training within 49 UK organisations 
(44 trusts in England, 3 health boards in Scotland, and 2 health boards in Wales), representing 120 
hospitals (64 acute, 37 community and 19 specialist: e.g. urgent care, cardio-thoracic). These 
responses have been included in the analysis. The replies to the survey were collated and tabulated 
for further analysis.  
 
 
Figure 1: Standardisation of infusion devices (n = 120) 
Standardisation  
Participants were asked whether standardisation had occurred across an entire hospital site, within 
only some clinical areas, or had not taken place at all. Figure 1 indicates that, across 120 hospitals, a 
high level of standardisation was reported, in relation to both volumetric infusion pumps (n = 92) 
and syringe pumps (n = 93). Fewer than 20% of hospitals had not standardised across all clinical 
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areas for volumetric pumps (n=23) and syringe pumps (n=22); only 4% reported there was no 
standardisation at all (n=5).  
 
To further investigate the extent of standardisation, respondents were asked to list which volumetric 
and syringe pumps were being used within their trusts. Table 1 indicates the different brands of 
devices that were mentioned in relation to this question (where n refers to the total number of 
brand mentions). The figures do not indicate individual makes or models of devices in use or 
variations between device types as detailed information was not always provided by respondents.  
 
Table 1: Brands of volumetric and syringe devices (where n = number of mentions)  
Brand Volumetric (n = 103) Syringe (n = 134) 
Alaris/Carefusion 37% 46% 
Arcomedical 7% 3% 
Baxter 12% N/A 
BBraun 15% 11% 
CME N/A 12% 
Fresenius 9% 6% 
Hospira 10% N/A 
Smiths/Graseby 10% 22% 
 
Of the 39 organisations who reported standardising their devices and where more detailed 
information about models was provided, the average number of types of volumetric devices listed 
per trust was 1.3 (range = 1-5). The average number of types of syringe devices was 2.8 per trust 
(range = 1-9).  
 
Device storage  
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Table 2 summarises the reported storage and management arrangements of infusion devices in 
terms of local storage and the use of central libraries across four clinical areas. While some areas use 
both centralised libraries and local storage systems, the most common approach was to store pumps 
in local areas only: critical care (62%, n = 50); general medicine (46%, n = 49); general surgery (41%, n 
= 38) and paediatrics (68%, n = 50). The use of centralised libraries alone does not appear to be very 
common, particularly within critical care (16%, n = 13) and paediatrics (7%, n = 5). 
 
Table 2: Device storage (rounded to the nearest percentage) 
 Centralised 
library 
Mixed 
approaches 
Storage in 
local clinical 
areas 
Number of 
hospital 
sites 
Critical Care 16% 22% 62% 81 
General Medicine 34% 20% 46% 108 
General Surgery 34% 25% 41% 92 
Paediatrics 7% 26% 67% 74 
 
Use of DERS 
 
Of the 49 respondents, 39 % (n = 19) reported using some form of DERS on at least one site within 
each organisation. However, the majority (55%, n = 27) were not, and 6% (n = 3) did not know 
whether DERS had been implemented.  Within the 19 organisations using DERS, 74% (n = 14) had 
DERS implemented on both volumetric and syringe devices, 11% (n = 4) had it enabled only on 
syringe devices) and the remaining organisation only on volumetric pumps.  These figures do not 
mean that DERS is being used across entire inventories, only that an organisation is using DERS on at 
least one type of volumetric and/or syringe device. 
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In terms of how DERS was used at an organisational level (i.e. across whole trusts or health boards), 
Table 3 indicates that most areas use a mixture of both hard and soft limits: critical care (72%, n = 
13); general medicine (70%, n = 7); general surgery (60%, n = 6); paediatrics (63%, n = 5). Out of the 
respondents, the most common area to utilise DERS was critical care (18 organisations) and the least 
common was paediatrics (8 organisations). Other specialist areas reported to use DERS include 
oncology and neonatal intensive care.  
 
Table 3: DERS use across 19 organisations (rounded to nearest percentage) 
 Only drug 
library 
Soft limits Hard limits Mix of 
limits 
Number of 
sites 
Critical Care 11% 6% 11% 72% 18 
General Medicine 0% 10% 20% 70% 10 
General Surgery 10% 10% 20% 60% 10 
Paediatrics 10% 14% 13% 63% 8 
Other areas 14% 0% 14% 72% 14 
 
On a site level, across 24 hospitals implementing DERS, almost all respondents reported updating 
drug libraries manually, (96%, n = 23), with only one hospital using wireless updates (4%, n = 1).  
 
Figure 2: DERS use across 24 hospital sites 
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Figure 2 illustrates that within specific hospitals, Critical Care is the most common area for DERS to 
be used (92%, n = 22). These results also suggest that DERS is not necessarily implemented across all 
areas within the same hospital. Some respondents also selected  “KƚŚĞƌĂƌĞĂƐ ?ŽĨZ^ƵƐĞ ?ǁŝƚŚƚŚĞ
most popular areas later specified as Neo-natal ICU (22%, n = 5) and Oncology (17%, n = 4). 
Reasons for not using DERS 
 
Of the 30 organisations who said they were not using DERS, 43% (n = 13) reported that there were 
no plans to introduce this technology within the next 12 months. Only 20% (n = 6) stated that there 
was a plan to do so, with a further high proportion of respondents not knowing about future plans 
(37%, n = 11). 
 
Respondents were asked to explain their choice of answer regarding the future plans for DERS and 
several reasons were provided for their being no plans to introduce this technology within the next 
12 months. For some, this was due to practical issues, such as being tied to an existing device 
contract e.g.  “ǆŝƐƚŝŶŐĚĞǀŝĐĞƐĚŽŶŽƚŚĂǀĞZ^ĐĂƉĂďŝůŝƚǇĂŶĚĂƌĞƉƌŽǀŝĚĞĚƵŶĚĞƌĐŽŶƚƌĂĐƚĨƌŽŵƚŚĞ
OEM [Original Equipment Manufacturer]. This contract has 18-24 months [to run] ? ? (Respondent 43). 
 
In addition, there were concerns about the lack of resources available e.g.   “dŚĞdƌƵƐƚĚŽĞƐŶŽƚŚĂǀĞ
ƚŚĞƌĞƐŽƵƌĐĞƐŽƌŝŶĨƌĂƐƚƌƵĐƚƵƌĞƚŽŝŵƉůĞŵĞŶƚZ^ ?, (Respondent 7); and the time required to 
implement DERS and train staff e.g.   “ZŝƐŬƐŽĨ ? ?ŝŶĐŽƌƌĞĐƚƵƐĞŽĨĚƌƵŐĞƌƌŽƌƌĞĚƵĐƚŝŽŶƐŽĨƚǁĂƌĞĚƵĞƚŽ
lack of training and high staff turnover and 2) the time and effort required to maintain drug libraries 
were felt to be significant enough to at least equal the benefits if not outweigh them ?, (Respondent 
36). 
 
Furthermore, there were some issues around not being able to standardise across an entire site e.g. 
 “dŚĞƌĞŝƐŶŽƚŚŝŶŐŝŶƚŚĞƉŝƉĞůŝŶĞƚŽŵǇŬŶŽǁůĞĚŐĞ ?ƚŚĞŬĞǇŚĞƌĞŝƐĞǀĞƌǇƉƵŵƉŚĂƐŝƚƐŽǁŶƐŽĨƚǁĂƌĞ
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which talks to its own pump. Problem is each of the softwares will not talk to each other, and 
standardisation is difficult when certain pumps are purchased for different criteria and application ?,  
(Respondent 41). This particular response also suggests there is an issue concerning lack of 
interoperability between multiple brands of device.  
 
Discussion 
The survey results suggest that in the last 10 years (since the NPSA alert in 2004), progress has been 
made towards the standardisation of infusion devices. Standardisation is particularly important to 
achieve before implementing DERS and is likely to aid nurses in their day to day tasks (Cousins et al, 
2013). There is room for improvement however, especially since Lee (2010) has shown that using a 
multidisciplinary group to help manage and achieve standardisation can reduce clinical risks 
effectively. There is also an indicatiŽŶƚŚĂƚƚŚĞƚĞƌŵ “ƐƚĂŶĚĂƌĚŝƐĂƚŝŽŶ ?ŵĂǇŶŽƚĂůǁĂǇƐŵĞĂŶƚŚĂƚ
one type of pump is being used across the whole hospital as there is still variability in the type of 
devices used. This is most likely due to specific areas, e.g. critical care and paediatrics, requiring 
different devices or alternative configurations of the same device. The fact that certain clinical areas 
require a different set up may be the main reason why centralised equipment libraries are not the 
most commonly used method of device storage management across entire hospitals.  
 
In addition, this survey provides empirical support regarding the use of DERS in the UK that was 
previously lacking (Cousins et al, 2013). The findings indicate that while there are a small number of 
hospitals and trusts who are starting to implement DERS, but it is less common for this form of 
technology to be used across an entire site or organisation. The most common usage of DERS 
appears to be in specialised areas such as Critical Care, with a mixture of hard and soft limits being 
the most frequent implementation across all areas.  
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Furthermore, it seems that organisations who wish to implement this type of technology need to 
overcome several challenges before being able to proceed. Similar to those noted by Upton and 
Quinn (2013), these challenges involve practical and organisational issues such as existing device 
contracts; the infrastructure and resources available; not being convinced that implementing the 
technology is worth the time and financial investment required, and complications related to a lack 
of standardisation and communication between devices. The survey findings indicate that many 
organisations are responsible for multiple sites, which can be at different stages of standardisation 
and use different types of infusion pumps; this is likely to further complicate the introduction of 
DERS across entire trusts and health boards.  
 
However, in terms of gathering the data, it was a real challenge to identify individuals who could 
answer all the questions included for each hospital within a single organisation. Multiple people, 
including manufacturers, are often involved in the procurement, management and setting up of 
infusion devices while job titles and departments are not always consistent. This difficulty means 
that response rates were lower than initially anticipated and also serves to highlight the complexity 
of working in the area of device management.  
 
This study was the first step in identifying the prevalence of DERS and considering related issues 
such as standardisation and effective infusion device management. The findings have established a 
foundation upon which to proceed with further research which is able to consider the effectiveness 
of DERS and possible recommendations for interventions relating to infusion devices that have 
greatest potential for aiding nurses in their day to day tasks and increasing patient safety. 
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